Global Sequencing Driven Metagenomics Market – Industry Trends and Forecast to 2026

  • Medical Devices
  • Upcoming Report
  • Aug 2019
  • Global
  • 350 Pages
  • No of Tables: 220
  • No of Figures: 60

Global Sequencing Driven Metagenomics Market By Product (Kits & Reagents, Sequencing & Data Analytics Services, Instruments, Consumables, Others), Application (Environmental, Human Health, Agriculture, Biotechnology, Biofuel, Others), End-Users (Pharmaceutical Industries, Biotechnology Companies, Research Laboratories, Pathology Laboratories, Academic & Research Institutes, Others), Geography (North America, Europe, Asia-Pacific, South America, Middle East and Africa) – Industry Trends and Forecast to 2026

Market Analysis: Global Sequencing Driven Metagenomics Market

Global sequencing driven metagenomics market is expected to register a steady CAGR in the forecast period of 2019-2026. The report contains data from the base year of 2018 and the historic year of 2017. This rise in market value can be attributed to the increasing investments undertaken by various organizations along with the increasing application areas of metagenomics in industries, life-sciences and biotechnological areas.

Market Definition: Global Sequencing Driven Metagenomics Market

Sequencing driven metagenomics is an innovative field of metagenomics study, wherein thousands of organisms are monitored in a parallel environment resulting in sampling of all genes associated with the organisms. This method involves actionable insights into the functioning and knowledge regarding the vast biodiversity of the environment, this technique helps in detection of microbes that are significantly low in numbers.

Market Drivers

  • Trend of decreased costs associated individual sequencing analysis is expected to drive the growth of the market
  • Increasing understanding and advancements in the technologies of DNA sequencing methods is also expected to drive the growth of the market
  • Availability of better understanding the functions, characteristics and strains of microbes in the environment through this technique are factors driving the growth of the market

Market Restraints

  • Lack in the availability of standards and inaccurate nature of this technique for diagnostic testing is also expected to restrict the adoption rate
  • Absence of knowledgeable professionals in the market is also expected to restrain the growth of the market

Segmentation: Global Sequencing Driven Metagenomics Market

By Product

  • Kits & Reagents

    • Library Preparation Kits
    • Sample Extraction Kits
    • Metagenomic Sequencing Kits

  • Sequencing & Data Analytics Services
  • Instruments
  • Consumables
  • Others

By Application

  • Environmental
  • Human Health

    • Infectious Disease Diagnostics
    • Gut Microbe Characterization

  • Agriculture
  • Biotechnology

    • Biosurfactants & Antibiotics Production
    • Clinical Diagnostics
    • Microbial Diversity

  • Biofuel
  • Others

By End-Users

  • Pharmaceutical Industries
  • Biotechnology Companies
  • Research Laboratories
  • Pathology Laboratories
  • Academic & Research Institutes
  • Others

    • Environmental Institutes
    • Chemical Companies
    • Others

By Geography

  • North America

    • U.S.
    • Canada
    • Mexico

  • Europe

    • Germany
    • Italy
    • U.K.
    • France
    • Spain
    • Netherlands
    • Belgium
    • Switzerland
    • Turkey
    • Russia
    • Rest of Europe

  • Asia-Pacific

    • Japan
    • China
    • India
    • South Korea
    • Australia
    • Singapore
    • Malaysia
    • Thailand
    • Indonesia
    • Philippines
    • Rest of Asia-Pacific

  • South America

    • Brazil
    • Rest of South America

  • Middle East and Africa

    • South Africa
    • Rest of Middle East and Africa

Key Developments in the Market:

  • In April 2019, Pacific Biosciences of California Inc. announced that they had initiated the commercialization of “Sequel II System”, inclusive of “SMRT Cell 8M”, instrument control software, chemistry and “SMRT Link” software package. This combined system will help in significant reduction of costs and time required as compared to the previous “Sequel System” available in the market
  • In November 2018, Illumina, Inc. announced that they had agreed to acquire Pacific Biosciences of California, Inc. This acquisition will help extend the capabilities of sequencing genomic solutions available with the company. This acquisition will extend Illumina’s short-read sequencing platforms by including the long-term sequencing platforms of Pacific Biosciences

Competitive Analysis:

Global sequencing driven metagenomics market is highly fragmented and the major players have used various strategies such as new product launches, expansions, agreements, joint ventures, partnerships, acquisitions, and others to increase their footprints in this market. The report includes market shares of sequencing driven metagenomics market for global, Europe, North America, Asia-Pacific, South America and Middle East & Africa.

Key Market Competitors:

Few of the major competitors currently working in the global sequencing driven metagenomics market are Danaher; Merck KGaA; Illumina, Inc.; Thermo Fisher Scientific Inc.; QIAGEN; F. Hoffmann-La Roche Ltd; Novogene Corporation; PerkinElmer Inc.; Arc Bio, LLC; Bio-Rad Laboratories, Inc.; Agilent Technologies, Inc.; Promega Corporation; Takara Bio Inc.; IntegraGen; Zymergen; Pacific Biosciences of California, Inc.; BGI; Eurofins Scientific; Macrogen Inc.;; CD Genomics; Microsynth AG; GENEWIZ; SciGenom Labs Pvt. Ltd; BaseClear B.V.; Swift Biosciences Inc.; ENTEROME; Aperiomics, Inc.; Second Genome and Cosmosid Inc among others.

Research Methodology: Global Sequencing Driven Metagenomics Market

Data collection and base year analysis is done using data collection modules with large sample sizes. The market data is analysed and forecasted using market statistical and coherent models. Also market share analysis and key trend analysis are the major success factors in the market report. To know more please request an analyst call or can drop down your enquiry.

The key research methodology used by DBMR research team is data triangulation which involves data mining, analysis of the impact of data variables on the market, and primary (industry expert) validation. Apart from this, other data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Company Market Share Analysis, Standards of Measurement, Top to Bottom Analysis and Vendor Share Analysis. To know more about the research methodology, drop in an inquiry to speak to our industry experts.

Primary Respondents

Demand Side: Doctors, Surgeons, Medical Consultants, Nurses, Hospital Buyers, Group Purchasing Organizations, Associations, Insurers, Medical Payers, Healthcare Authorities, Universities, Technological Writers, Scientists, Promoters, and Investors among others.

Supply Side: Product Managers, Marketing Managers, C-Level Executives, Distributors, Market Intelligence, and Regulatory Affairs Managers among others.

Reasons to Purchase this Report

  • Current and future of global sequencing driven metagenomics market outlook in the developed and emerging markets
  • The segment that is expected to dominate the market as well as the segment which holds highest CAGR in the forecast period
  • Regions/Countries that are expected to witness the fastest growth rates during the forecast period
  • The latest developments, market shares, and strategies that are employed by the major market players

Customization of the Report:

  • All segmentation provided above in this report is represented at country level
  • All products covered in the market, product volume and average selling prices will be included as customizable options which may incur no or minimal additional cost (depends on customization)


Please fill in the below form for detailed Table of Content

Please fill in the below form for detailed List of Table

Please fill in the below form for detailed List of Figure

  • 7000.00
  • 4800.00
  • 3000.00
  • 8000.00
  • 12000.00
Why Choose Us
Unlocking New Opportunities on this Report Post Covid-19